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The possibilities of jow injection analysis for the on-line
monitoring of dissolution tests are illustrated by using a very
straightforward manifold to monitor tablets of ascorbic acid
dissolving at different rates. The dissolution kinetics can be
monitored at an adequate samplingfrequency as the method allows
up to 90 samples to be processed per hour.
Flow Injection Analysis (FIA) has proved to be a useful
tool for on-line process monitoring 1,2] and pharmaceut-
ical analysis [3-5]. Both applications are of great
importance in the monitoring of dissolution tests of solid
dosage forms. Dissolution tests on pharmaceuticals are
commonplace quality control procedures and facilitate
meeting the legal requirements for compendial drugs,
and for oral-dosage forms which are not yet listed in
compendia.
Conventional approaches to the monitoring ofdissolution
processes occurring simultaneously in the ’controller’,
according to the requirements established by pharmaco-
poeia regulations, include the following: (1) an auto-
mated selecting valve sequentially driving a small volume
of the evolving system to the single flow-cell of a
photometric detector, or to a dedicated detector with six
flow-cells, each receiving the stream from one vessel (both
alternatives monitoring the native absorbance of an
active compound); (2) the use of a sampler as a interface
between the dissolution vessel and the instrument
(generally a high-pressure liquid chromatograph); and
(3) in-line monitoring. These approaches suffer from a
series of shortcomings such as: (a) the difficulty of
controlling non-specific, or non-selective, active com-
pounds (for example the case of absorption spectra
overlapping with those of other components in the oral-
dosage); (b) the process is controlled in anything but real-
time- very expensive instrumentation and maintenance
costs would be involved if real-time was used; (c)
measurement errors arise from the presence of variable
amounts of suspended solids and these result in complex
and imprecise data treatment.
The need for new instrumentation and methods for
monitoring of dissolution tests increases day by day,
fostered by the manufacture of new drugs with widely
different dissolution rates, and by the need for stricter
quality control as a result of the growing competition in
international markets.
This paper aims to show the suitability of FIA in
adapting existing methodologies to the kinetics of the
dissolution process. A photometric method was devel-
oped for the determination of ascorbic acid, and then
adapted to the monitoring of this analyte in tablets with
fast and slow dissolution kinetics.
Experimental
Instruments and apparatus
A Perkin-Elmer Lambda-1 single-beam spectropho-
tometer was used. This was equipped with a Hellma 178
12QS flow-cell and connected to a Radiometer REC-80
recorder, and Hewlett-Packard PH-85 microcomputer,
through an HP-IB 82937A interface. A Gilson
Minipuls-2 four-channel peristaltic pump, a Tecator
L-100 injection valve and two Omnifit 2407 confluence
points were also used.
Reagents
Aqueous solutions of 3 x 10-4M chloramine T, 0.2M
H2SO4, starch potassium iodide mixture (1 g/1 soluble
starch + 2 g/1 KI) and standards of ascorbic acid were
prepared daily.
Results and discussion
Manifold and chemical system
The manifold used for the optimization of variables is
shown in figure 1; the dissolution vessel was replaced with
a flask containing the sample solution of ascorbic acid.
This sample, dissolved in an acidic medium, was injected
into the chloralnine T-stream after merging with a starch-
iodide stream. Iodide forms HI in an acid media, which
subsequently reacts with chloramine T. The iodine
formed oxidizes vitamin C. Once vitamin C has been fully
consumed, iodine binds to starch, which constitutes the
indicator reaction. Sulphuric acid is added directly to the
injected sample volume. This stream then converges with
the chloramine T-stream, thus avoiding precipitation of
the reagent. No iodine was consumed when the sample
contained only sulphuric acid, due to the absence of
vitamin C, and the signal obtained was maximum. The
presence of vitamin C reduced the analytical signal in
proportion to its concentration.
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Figure 1. FIA manifoldfor the monitoring of dissolution tests on pharmaceutical dosages containing ascorbic acid.
Optimization of variables
The optimum values for the FIA variables (see figure 1)
were as follows: flow-rate (q) 2"04 ml/min; injected
volume (V/) 96"2 tl; reactor length (R], R2) 50 and 55
cm, respectively; inner diameter of the reactors () 0"5
mm. These values allowed the blue colour of the starch-
iodine complex to be formed as the sample plug passed
through the detector, then it was monitored at 581 nm.
The optimization of the variables ensured the maximum
difference between the reference and the sample peaks.
The influence of the chloramine T concentration was one
of the most important variables in this determination. At
high concentrations of chloramine T, the presence of
vitamin C had no effect on the analytical signal. The
maximum difference between the blank and the sample
signal was obtained with 3 x 10-4M chloramine T
solutions. At lower concentrations, the absorbance differ-
ence decreased owing to the drastic weakening of the
blank signal.
The pH of the sample was adjusted by adding H2SO4.
The reaction medium must be acidic to allow the
formation of HI. The absorbance difference between the
blank and the sample was high at low pH. At sulphuric
acid concentrations above 0"75M the signal difference
increased only slightly and some peak broadening was
observed. A 0"90M sulphuric acid concentration was
chosen as optimum. The most suitable concentrations of
KI and starch are set out in the ’Experimental’ section of
this paper.
It is well known that high temperatures hinder the
development of the blue colour of the starch-iodine
complex; therefore, the experiments were performed at
room temperature.
where A is the absorbance difference between the blank
and the sample containing vitamin C (whose concentra-
tion is expressed in tg/ml). The equation covers the
calibration range between 15 and 150 tg/ml, the r.s.d.
(p 0"05) for the determination of 100 g/ml ofvitamin C
being 0"97%. The sampling frequency was 90 h-].
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Determination of vitamin C
This method allows the determination ofvitamin C from
the equation:
A 0"117 + 0’003 [vitamin C]; r 0"999
TIME
Figure 2. Recording obtained in the monitoring oftablets withfast
dissolution kinetics. The envelope ofthe maxima ofthepeaks shows
the nature of the kinetics.
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Figure 3. Recording obtained in the monitoring of tablets ofslow dissolution kinetics. The envelope is representative of the dissolution rate.
On-line monitoring of ascorbic acid dosage forms with different
dissolution kinetics
Prior to starting the dissolution process, a triplicate
injection ofthe dissolving solution was performed and the
average of this blank signal was stored in the microcom-
puter. Then, the tablet was introduced into the stirring
basket and injection from the solution in the vessel were
performed at preselected time intervals, the absorbance-
time data were also collected by the microcomputer (the
blank value and the calibration curve had been pre-
viously input). In this way, a simple program written in
BASIC was used to collect a table of time-analyte
concentration values and, hence, the concentration of
ascorbic acid at any moment during the process. A
recorder connected to the detector also allows the visual
monitoring of the process through the recording of the
peaks corresponding to the evolution of the tablet. The
envelope of the maxima of the FIA peaks was a kinetic
curve of the dissolution process. The approach was tested
with two types of ascorbic acid dosage forms, Treasury
and Redoxon, with different dissolution kinetics because
Treasury (timed release tablets) were furnished with a
special molecular sieve which retarded the dissolution
process, while Redoxon tablets have a very fast dissolu-
tion rate. Figures 2 and 3 show the recordings for the two
tablets; the fast dissolution of the Redoxon tablets (figure
2) and the slower rate of the Treasury tablets (figure 3)
are very clear.
Final remarks
This paper shows the value ofFIA for on-line monitoring
ofdissolution tests. The method developed here features a
number of interesting advantages:
(1) Small sample consumption (the sample can be
returned to the vessel once the loop of the injection
valve has been filled).
(2) A derivatizing reaction can be readily implemen-
ted to improve analytical features of the determi-
nation, such as sensitivity and/or selectivity. In
addition, reagent consumption is very small and a
variety of chemical systems (as described by
Koupparis et al. [6-9]) and detectors can be used.
(3) The response is obtained in near to real-time, in
contrast with the conventional devices used for this
purpose.
(4) The high sample throughput allows frequent
monitoring as required, by the rate of real-time
being studied. This is of great value for fast
dissolution kinetics.
(5) In addition, the on-line separation technique can
be readily implemented whenever the analytes
require such treatment 10].
(6) FIA can be adapted to the monitoring of any type
of dissolution kinetics demonstrated in this work.
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